SIMPONI ARIA (Janssen Biotech, Inc.)
Welcome to the PulseAid listing for the SIMPONI ARIA drug offered from Janssen Biotech, Inc.. This Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Janssen Biotech, Inc. |
| NON-PROPRIETARY NAME: | golimumab |
| SUBSTANCE NAME: | GOLIMUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2013-07-19 |
| END MARKETING DATE: | 0000-00-00 |
SIMPONI ARIA HUMAN PRESCRIPTION DRUG Details:
| Item Description | SIMPONI ARIA from Janssen Biotech, Inc. |
| LABELER NAME: | Janssen Biotech, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/4mL) |
| START MARKETING DATE: | 2013-07-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 57894-350_c768f495-1a81-4956-9494-80e768262117 |
| PRODUCT NDC: | 57894-350 |
| APPLICATION NUMBER: | BLA125433 |
Other GOLIMUMAB Pharmaceutical Manufacturers / Labelers:
